Performant Financial (US:PFMT)2022-08-09 20:45Revenue Performance - Total revenues for the six months ended June 30, 2022, were $52.8 million, a decrease from $64.2 million in the same period of 2021, representing a decline of approximately 17%[78] - Total revenues for the three months ended June 30, 2022, were $25.7 million, a decrease of approximately 22% compared to $32.8 million for the same period in 2021[115] - Total revenues for the six months ended June 30, 2022, were $52.8 million, a decrease of approximately 18% compared to $64.2 million for the same period in 2021[125] Healthcare Revenue - Healthcare revenues for the six months ended June 30, 2022, were $21.8 million, up from $18.6 million in the same period of 2021, indicating a growth of about 17%[80] - Healthcare revenues increased to $21.8 million for the three months ended June 30, 2022, representing a growth of $3.2 million, or 17%, compared to the same period in 2021[116] - Healthcare revenues for the six months ended June 30, 2022, were $45.1 million, an increase of $13.2 million, or 41%, compared to the same period in 2021[126] - The company anticipates that healthcare revenues will drive the majority of overall revenue growth moving forward[86] Recovery Revenue - Recovery revenues dropped to $7 thousand for the three months ended June 30, 2022, down from $11.1 million in the same period of 2021, primarily due to the sale of certain recovery contracts[117] - Recovery revenues for the six months ended June 30, 2022, were $124 thousand, a significant decrease from $25.6 million in the same period of 2021[127] - The company sold certain non-healthcare recovery contracts in 2021 and does not expect significant revenues from the non-healthcare recovery market going forward[87] Operating Expenses - The company’s operating expenses primarily consist of salaries and benefits, along with other operating expenses related to subcontractors and production[89] - Total operating expenses for the three months ended June 30, 2022, were $28.98 million, a decrease of 15% from $34.05 million in the same period of 2021[114] - Salaries and benefits expense for the six months ended June 30, 2022, was $41.3 million, a decrease of $6.1 million, or 13%, compared to $47.4 million for the same period in 2021[129] Net Loss - Net loss for the three months ended June 30, 2022, was $3.2 million, an increase of approximately $1.7 million, or 108%, compared to a net loss of $1.5 million for the same period in 2021[123] - Net loss for the six months ended June 30, 2022, was $4.8 million, a decrease of $1.2 million or 19% compared to a net loss of $6.0 million for the same period in 2021[134] Cash Flow and Financing - Cash used in operating activities was $5.5 million for the six months ended June 30, 2022, compared to cash provided of $1.5 million for the same period in 2021[145] - Cash used in investing activities was $1.2 million for the six months ended June 30, 2022, primarily for capital expenditures related to IT systems, compared to $0.8 million in 2021[146] - Cash provided by financing activities was $5.3 million for the six months ended June 30, 2022, mainly from proceeds of $5.6 million from warrant exercises, contrasting with cash used of $8.4 million in 2021[147] - As of June 30, 2022, cash and cash equivalents totaled $18.2 million, down from $19.6 million as of December 31, 2021[142] Debt and Interest - The company has a $20 million term loan commitment under its Credit Agreement, fully advanced, and a $15 million revolving loan commitment, which remains undrawn as of June 30, 2022[149] - The outstanding amount under the Credit Agreement was $19.8 million as of June 30, 2022, with an interest rate of 3.8%[150] - Interest expense decreased to $0.4 million for the six months ended June 30, 2022, down from $3.5 million for the same period in 2021, a reduction of approximately 89%[132] - The Credit Agreement allows for interest rates on loans to range from 2.50% to 3.00% per annum for term SOFR loans and from 1.50% to 2.00% per annum for base rate loans, depending on the leverage ratio[153] - If the interest rate on borrowings increased by 100 basis points (1%) from the credit facility floor of 1.0%, the annual interest expense would increase by approximately $0.2 million[156] Compliance and Covenants - As of June 30, 2022, the Company was in compliance with all financial covenants, maintaining a total leverage ratio of not greater than 3.00 to 1.00 through September 30, 2022, and a fixed charge coverage ratio of not less than 1.20 to 1.00[154] - The Credit Agreement contains customary representations, warranties, and covenants that restrict certain actions, including incurrence of indebtedness and mergers[154] - The Company has a commitment fee on unused availability of the revolving credit facility, which may vary from 0.30% to 0.40% per annum based on the leverage ratio[153] Strategic Focus - The company’s claims-based audit business is influenced by the volume of permissible claims, which can be affected by various factors including regulatory changes and the COVID-19 pandemic[92] - The company reported a significant decline in recovery revenues due to regulatory changes and the impact of the COVID-19 pandemic, leading to strategic shifts in focus[87] - The Company may invest excess cash in short-term investments, which could be affected by changes in market interest rates, impacting both interest expense and interest income[157]